Primary study · included by 1 review
Overexpression of cysteine-glutamate transporter and CD44 for prediction of recurrence and survival in patients with oral cavity squamous cell carcinoma.
Lee 2018 · Lee Jae Ryung, Roh Jong-Lyel, Lee Sun Mi, et al. · Head & neck · 2018
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Overall survival CSC-positive immunophenotype by tissue immunohistochemistry (CD44, CD133, xCT/SLC7A11) vs CSC-negative or low immunophenotype | HR 2.01 [1.42, 2.84] | 2 studies | Low |
Overall survival CSC-positive immunophenotype by tissue immunohistochemistry (CD44, CD133, xCT/SLC7A11) vs CSC-negative or low immunophenotype | HR 0.77 [0.16, 3.81] | 3 studies | GRADE not reported |
1 including review in total.